(Q48653248)

13 February 2018

title

Gastrointestinal cancer: Tracking tumour evolution through liquid biopsy (English)

1 reference

13 February 2018

Charles Swanton

2

0 references

author name string

Samra Turajlic

series ordinal

1

1 reference

13 February 2018

language of work or name

English

0 references

publication date

8 September 2015

1 reference

13 February 2018

Nature Reviews Clinical Oncology

published in

1 reference

13 February 2018

volume

12

1 reference

13 February 2018

issue

10

1 reference

13 February 2018

page(s)

565-566

1 reference

13 February 2018

Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Tracking genomic cancer evolution for precision medicine: the lung TRACERx study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2015.153

Inferring mutational timing and reconstructing tumour evolutionary histories

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26346844

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2015.153

1 reference

13 February 2018

1 reference

13 February 2018